Mezzion Pharma Co.Ltd (140410) - Total Liabilities

Latest as of September 2025: ₩50.54 Billion KRW ≈ $34.25 Million USD

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has total liabilities worth ₩50.54 Billion KRW (≈ $34.25 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Mezzion Pharma Co.Ltd generate cash to assess how effectively this company generates cash.

Mezzion Pharma Co.Ltd - Total Liabilities Trend (2012–2024)

This chart illustrates how Mezzion Pharma Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Mezzion Pharma Co.Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Mezzion Pharma Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Aekyung Petrochemical Co Ltd KO:161000	Korea	₩664.72 Billion
Chang Lan Electric Technology Co Ltd SHE:002879	China	CN¥756.61 Million
Altia Consultores S.A. MC:ALC	Spain	€84.19 Million
Upstream Bio, Inc. NASDAQ:UPB	USA	$12.61 Million
Braiin Limited Common Stock NASDAQ:BRAI	USA	$65.98 Million
Shanghai Yongguan Adhesive Products Corp Ltd SHG:603681	China	CN¥4.35 Billion
TPI Polene Public Company Limited BK:TPIPL	Thailand	฿96.12 Billion
Flotek Industries Inc NYSE:FTK	USA	$106.99 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Mezzion Pharma Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 140410 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mezzion Pharma Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mezzion Pharma Co.Ltd (2012–2024)

The table below shows the annual total liabilities of Mezzion Pharma Co.Ltd from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩27.94 Billion ≈ $18.93 Million	-9.02%
2023-12-31	₩30.70 Billion ≈ $20.81 Million	+10.52%
2022-12-31	₩27.78 Billion ≈ $18.83 Million	+31.41%
2021-12-31	₩21.14 Billion ≈ $14.33 Million	+12.36%
2020-12-31	₩18.82 Billion ≈ $12.75 Million	+17.28%
2019-12-31	₩16.04 Billion ≈ $10.87 Million	-9.56%
2018-12-31	₩17.74 Billion ≈ $12.02 Million	-14.99%
2017-12-31	₩20.87 Billion ≈ $14.14 Million	-51.57%
2016-12-31	₩43.09 Billion ≈ $29.20 Million	+6.35%
2015-12-31	₩40.52 Billion ≈ $27.46 Million	+921.54%
2012-12-31	₩3.97 Billion ≈ $2.69 Million	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$507.93 Million

₩749.51 Billion KRW

Market Cap Rank

#12458 Global

#396 in Korea

Share Price

₩87700.00

Change (1 day)

-8.65%

52-Week Range

₩36400.00 - ₩172700.00

All Time High

₩172700.00